BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30790682)

  • 1. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA.
    He J; Zuo Q; Hu B; Jin H; Wang C; Cheng Z; Deng X; Yang C; Ruan H; Yu C; Zhao F; Yao M; Fang J; Gu J; Zhou J; Fan J; Qin W; Yang XR; Wang H
    Cancer Lett; 2019 May; 450():98-109. PubMed ID: 30790682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.
    Zhang J; Hu K; Yang YQ; Wang Y; Zheng YF; Jin Y; Li P; Cheng L
    Cell Death Dis; 2020 Sep; 11(9):741. PubMed ID: 32917856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
    Xu Y; Zheng Y; Liu H; Li T
    Int J Oncol; 2017 Sep; 51(3):791-800. PubMed ID: 28677801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00467 promotes cell proliferation and metastasis by binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in hepatocellular carcinoma.
    Jiang W; Cheng X; Wang T; Song X; Zheng Y; Wang L
    J Gene Med; 2020 Mar; 22(3):e3134. PubMed ID: 31656043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression.
    Wei L; Ling M; Yang S; Xie Y; Liu C; Yi W
    Hum Cell; 2021 Mar; 34(2):539-549. PubMed ID: 33387362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma.
    Xu F; Li CH; Wong CH; Chen GG; Lai PBS; Shao S; Chan SL; Chen Y
    Cancer Res; 2019 Apr; 79(7):1305-1317. PubMed ID: 30718359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of a novel LncRNA AC104958.2 stabilized by PCBP2 promotes proliferation and microvascular invasion in hepatocellular carcinoma.
    Ma Z; Li S; Wang Y; Zhang J; Zeng X
    Exp Cell Res; 2021 Oct; 407(1):112791. PubMed ID: 34418457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00641 impeded the malignant biological behaviors of papillary thyroid carcinoma cells via interacting with IGF2BP1 to reduce GLI1 mRNA stability.
    Meng D; Zhao S; Wu L; Ma X; Zhao D; Li Z
    Hum Exp Toxicol; 2023; 42():9603271231180856. PubMed ID: 37291850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Long Noncoding RNAs,
    Qin Y; Tu X; Huang M; Ma C; Huang Q; Huang Q; Shu H; Ou C
    DNA Cell Biol; 2023 Aug; 42(8):488-497. PubMed ID: 37527208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
    Rong Z; Wang Z; Wang X; Qin C; Geng W
    J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
    Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.